- $34.83m
- $15.24m
- $152.44m
- 84
- 97
- 37
- 84
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 152 | 130 | 149 | 165 | 152 |
Cost of Revenue | |||||
Gross Profit | 52 | 44.7 | 52.5 | 61.7 | 52.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 157 | 131 | 143 | 145 | 150 |
Operating Profit | -4.95 | -1.52 | 5.94 | 20.5 | 2.03 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -17.4 | -13.8 | 0.064 | 20.2 | 2.17 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.8 | -14.3 | 0.006 | 19.6 | 9.42 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.8 | -14.3 | 0.006 | 19.6 | 9.42 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.8 | 10.1 | 0.006 | 19.6 | 9.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.03 | 0.7 | 0.01 | 0.073 | 0.087 |